# Hypovitaminosis D in Neurocritical Patients

> **NCT02881957** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Utah** · enrollment: 274 (actual)

## Conditions studied

- Craniocerebral Trauma
- Intracranial Aneurysm
- Brain Neoplasms
- Spinal Cord Injuries
- Seizures
- Meningitis
- Stroke
- Intracranial Hemorrhages
- Critical Illness
- Vitamin d Deficiency

## Interventions

- **DRUG:** Cholecalciferol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02881957
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-10
- **Primary completion:** 2018-10-10
- **Final completion:** 2018-10-10
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881957, "Hypovitaminosis D in Neurocritical Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02881957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*